Kardiogener Schock: Medikamentöse Therapie – Herzunterstützungssysteme

kardiogener Schock - Myokardinfarkt - S3-Leitlinie - mechanische Herzunterstützung

cardiogenic shock - myocardial infarction - guideline - cardiac support

Literatur

• 1 Buerke M, Lemm H, Krohe K. et al . Levosimendan in the treatment of cardiogenic shock.  Minerva Cardioangiol. 2010;  58 519-530
• 2 Buerke M, Lemm H, Dietz S, Werdan K. Pathophysiology, diagnosis and treatment of infarction-related cardiogenic shock.  Herz. 2011;  36 73-83
• 3 Engström A E, Cocchieri R, Driessen A H. et al . The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience.  Crit Care Med. 2011;  39 2072-2079
• 4 Kar B, Gregoric I D, Basra S S, Idelchik G M, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock.  J Am Coll Cardiol. 2011;  57 688-696
• 5 Lamarche Y, Cheung A, Ignaszewski A, Higgins J, Kaan A, Griesdale D EG, Moss R. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support.  J Thorac Cardiovasc Surg. 2011;  142 60-65
• 6 Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.  Crit Care Med. 2011;  39 450-455
• 7 Maggioni A P, Dahlström U, Filippatos G. et al . on behalf of the Heart Failure Association of the ESC (HFA): EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot).  Eur J Heart Fail. 2010;  12 1076-1084
• 8 Mantziari L, Guha K, Senguttuvan N B, Sharma R. Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction.  Int J Cardiol. 2011;  ; Epub ahead of print
• 9 Mebazaa A, Parissis J, Porcher R. et al . Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods.  Intens Care Med. 2011;  37 290-301
• 10 Prondzinsky R, Lemm H, Swyter M. et al . Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial for attenuation of multiorgan dysfunction syndrome.  Crit Care Med. 2010;  38 152-160
• 11 Sheu J -J, Tsai T -H, Lee F-Y. et al . Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profund cardiogenic shock.  Crit Care Med. 2010;  38 1810-1817
• 12 Unverzagt S, Mechemer M T, Solms A. et al . Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.  Cochrane Database Syst Rev. 2011; ;  CD007398
• 13 Werdan K, Ruß M, Buerke M. Chapter 29 The intra-aortic balloon pump. In: Tubaro M, Danchin N, Filippatos G, Goldstein P, Vranckx P, Zahger D Intensive and Acute Cardiac Care. Oxford University Press ; 2011: 277-288
• 14 Werdan K, Ruß M, Buerke M. et al . Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“.  Intensivmed. 2011;  48 291-344 Erratum 402